title: Remission of severe neonatal diabetes with very early sulfonylurea treatment.
authors.affiliation: Department of Pediatrics, Washington University School of Medicine, St. Louis, MO Department of Cell Biology, Washington University School of Medicine, St. Louis, MO marshall@kids.wustl.edu.
authors.forename: Bess A
authors.initials: BA
authors.lastname: Marshall
authors.affiliation: Springfield Clinic, Springfield, IL.
authors.forename: Rebecca P
authors.initials: RP
authors.lastname: Green
authors.affiliation: Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Wambach
authors.affiliation: Department of Pediatrics, Washington University School of Medicine, St. Louis, MO.
authors.forename: Neil H
authors.initials: NH
authors.lastname: White
authors.affiliation: Department of Cell Biology, Washington University School of Medicine, St. Louis, MO.
authors.forename: Maria S
authors.initials: MS
authors.lastname: Remedi
authors.affiliation: Department of Cell Biology, Washington University School of Medicine, St. Louis, MO.
authors.forename: Colin G
authors.initials: CG
authors.lastname: Nichols
mesh_terms: D002648:Child; D003920:Diabetes Mellitus / Q000151:congenital* / Q000188:drug therapy*; D004334:Drug Administration Schedule; D061345:Early Medical Intervention; D005260:Female; D005905:Glyburide / Q000627:therapeutic use*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007231:Infant, Newborn; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D012074:Remission Induction; D012720:Severity of Illness Index; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds; D005905:Glyburide